| Oct 9 |
Cassava Sciences: Phase III trials storm ahead amid controversy
|
| Oct 8 |
Sector Update: Health Care Stocks Rise Late Afternoon
|
| Oct 8 |
What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday?
|
| Oct 8 |
Cassava Sciences earns rare buy as H.C. Wainwright upgrades post settlement
|
| Oct 2 |
Cassava's Alzheimer's Therapy: A Confidence Bet
|
| Sep 30 |
SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims
|
| Sep 30 |
Company News for Sep 30, 2024
|
| Sep 29 |
Wall Street Breakfast: The Week Ahead
|
| Sep 27 |
Why Cassava Sciences Stock Dived by Almost 11% Today
|
| Sep 27 |
Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims
|
